Godavari Biorefineries

Godavari Biorefineries delivered a strong Q4 FY26 with revenue from operations of ₹564 croreCurrent reported value: ₹564 crore. No comparable prior figure is available in the source record. and EBITDA of ₹92 croreCurrent reported value: ₹92 crore. No comparable prior figure is available in the source record. (16.2Current reported value: 16.2. No comparable prior figure is available in the source record.% margin), driven by record cane crushing of 2.5 million tonsCurrent 2.5 million tons. Reported change: Highest ever. and improved sugar operations. PAT surged to ₹52.9 croreCurrent reported value: ₹52.9 crore. No comparable prior figure is available in the source record. from a loss in Q3, reflecting operational leverage and a 32% reduction in finance costs after repaying ₹240 crore debt. The bio-based chemicals segment saw margins double QoQ to 16.2%, though specialty mix dipped to 61%Current 61%. Reported change: +3pp YoY. as management opportunistically ran ethyl acetate. The 200 KPD grain distillery (60 million liters annual capacity) is on track for commissioning trials in June 2026. Management guided for stronger bio-chemical demand in FY27 due to narrowing fossil-renewable price gaps. Key risk: ethanol price revision remains uncertain, and the grain distillery could face margin pressure if maize prices stay elevated.